Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib + Capecitabine in Metastatic Breast Cancer
NCT00087152Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2004
- Primary completion
- Dec 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of imatinib in breast cancer, sponsored by National Cancer Institute. Started Jun 2004; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00087152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087152.